Literature DB >> 10900169

Oxidative stress increases synthesis of big endothelin-1 by activation of the endothelin-1 promoter.

J Kähler1, S Mendel, J Weckmüller, H D Orzechowski, C Mittmann, R Köster, M Paul, T Meinertz, T Münzel.   

Abstract

Modulation of the biosynthesis of the vasoconstrictor peptide endothelin-1 by oxygen-derived free radicals generated by xanthine oxidase or hydrogen peroxide was studied in cultured endothelial cells. Endothelin-1 metabolism was investigated at the level of endothelin-1 promoter, preproendothelin-1 mRNA and intracellular big endothelin-1. Endothelin-1 mRNA, as characterized by Northern blotting, was increased both time- and dose-dependently by xanthine oxidase to up to 500% above baseline. Analysis of endothelin-1 promoter activity using a construct containing 1329 bp of the endothelin-1 promoter revealed that promoter activity was increased up to eight-fold by incubation with xanthine oxidase. Specificity was ascertained by co-incubation with superoxide dismutase and catalase leading to inhibition of the effect of xanthine oxidase. A significant contribution of nitric oxide was ruled out, since NOS III-mRNA transcription remained unchanged and l -NAME did not significantly alter endothelin-1 promoter activity. Synthesis of intracellular big endothelin-1 protein was increased dose-dependently by xanthine oxidase. Our results indicate that oxidative stress leads to increased endothelial synthesis of big endothelin-1, which is a previously unknown mechanism and may help to understand the detrimental association of increased oxidative stress and elevated endothelin-1 levels in pathophysiological conditions promoting atherosclerosis. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10900169     DOI: 10.1006/jmcc.2000.1178

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  34 in total

Review 1.  Inhibition of the renin angiotensin system: implications for the endothelium.

Authors:  Carmine Savoia; Ernesto L Schiffrin
Journal:  Curr Diab Rep       Date:  2006-08       Impact factor: 4.810

Review 2.  Reactive species-induced microvascular dysfunction in ischemia/reperfusion.

Authors:  Hong Yu; Ted Kalogeris; Ronald J Korthuis
Journal:  Free Radic Biol Med       Date:  2019-03-05       Impact factor: 7.376

3.  Protective effect of 4,4'-diaminodiphenylsulfone against paraquat-induced mouse lung injury.

Authors:  Sung Chun Cho; Ji Heon Rhim; Hae Ri Choi; Young Hoon Son; Seok Jin Lee; Kye Yong Song; Sang Chul Park
Journal:  Exp Mol Med       Date:  2011-09-30       Impact factor: 8.718

4.  Bosentan, the mixed ETA-ETB endothelin receptor antagonist, attenuated oxidative stress after experimental myocardial ischemia and reperfusion.

Authors:  Suresh K Gupta; Amit Saxena; Uma Singh; Dharamvir S Arya
Journal:  Mol Cell Biochem       Date:  2005-07       Impact factor: 3.396

5.  Endothelial dysfunction occurs independently of adipose tissue inflammation and insulin resistance in ovariectomized Yucatan miniature-swine.

Authors:  Thomas J Jurrissen; T Dylan Olver; Nathan C Winn; Zachary I Grunewald; Gabriela S Lin; Jessica A Hiemstra; Jenna C Edwards; Michelle L Gastecki; Rebecca J Welly; Craig A Emter; Victoria J Vieira-Potter; Jaume Padilla
Journal:  Adipocyte       Date:  2017-12-28       Impact factor: 4.534

6.  Role for reactive oxygen species in flow-stimulated inner medullary collecting duct endothelin-1 production.

Authors:  Will Wheatley; Donald E Kohan
Journal:  Am J Physiol Renal Physiol       Date:  2017-05-17

Review 7.  Role of endothelin-1 in hypertension.

Authors:  Marc Iglarz; Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

8.  Endothelin-1 and asymmetric dimethylarginine in children with left-to-right shunt after intracardiac repair.

Authors:  Tsvetomir Loukanov; Raoul Arnold; Jasmin Gross; Christian Sebening; Homa Klimpel; Joachim Eichhorn; Katharina Hoss; Herbert E Ulmer; Matthias Kark; Matthias Gorenflo
Journal:  Clin Res Cardiol       Date:  2008-02-22       Impact factor: 5.460

9.  Intermittent hypoxia-induced increases in reactive oxygen species activate NFATc3 increasing endothelin-1 vasoconstrictor reactivity.

Authors:  J K Friedman; C H Nitta; K M Henderson; S J Codianni; L Sanchez; J M Ramiro-Diaz; T A Howard; W Giermakowska; N L Kanagy; L V Gonzalez Bosc
Journal:  Vascul Pharmacol       Date:  2013-11-15       Impact factor: 5.773

Review 10.  Targeting vascular (endothelial) dysfunction.

Authors:  Andreas Daiber; Sebastian Steven; Alina Weber; Vladimir V Shuvaev; Vladimir R Muzykantov; Ismail Laher; Huige Li; Santiago Lamas; Thomas Münzel
Journal:  Br J Pharmacol       Date:  2016-07-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.